Literature DB >> 15869571

Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes.

M-F Scully1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15869571     DOI: 10.1111/j.1538-7836.2005.01396.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  1 in total

1.  Life-threatening cardiac manifestations of primary antiphospholipid syndrome.

Authors:  Rafal Grzybczak; Anetta Undas; Pawel Rostoff; Andrzej Gackowski; Urszula Czubek; Katarzyna Stopyra; Wieslawa Piwowarska
Journal:  Heart Vessels       Date:  2010-05-29       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.